Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 184 | 51606 | 38.1 | 65% |
Classes in level above (level 4) |
Classes in level below (level 2) |
| ID, lev. below |
Publications | Label for level below |
|---|---|---|
| 278 | 18430 | RISPERIDONE//CLOZAPINE//OLANZAPINE |
| 452 | 15404 | BIPOLAR DISORDERS//JOURNAL OF AFFECTIVE DISORDERS//MANIA |
| 667 | 12573 | ANTIDEPRESSANTS//AGOMELATINE//MOCLOBEMIDE |
| 2268 | 4213 | ELECTROCONVULSIVE THERAPY//JOURNAL OF ECT//CONVULSIVE THERAPY |
| 3530 | 986 | DRUG INDUCED DEPRESSION//BUZEPIDE METHIODIDE//DEPRESSIVE DISORDER CHEMICALLY INDUCED |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | BIPOLAR DISORDERS | Author keyword | 2068 | 40% | 8% | 4006 |
| 2 | ELECTROCONVULSIVE THERAPY | Author keyword | 1261 | 69% | 2% | 1089 |
| 3 | JOURNAL OF CLINICAL PSYCHIATRY | Journal | 1198 | 38% | 5% | 2537 |
| 4 | JOURNAL OF ECT | Journal | 958 | 74% | 1% | 701 |
| 5 | OLANZAPINE | Author keyword | 835 | 56% | 2% | 1027 |
| 6 | JOURNAL OF AFFECTIVE DISORDERS | Journal | 824 | 31% | 4% | 2240 |
| 7 | RISPERIDONE | Author keyword | 790 | 55% | 2% | 990 |
| 8 | CLOZAPINE | Author keyword | 685 | 45% | 2% | 1148 |
| 9 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | Journal | 623 | 43% | 2% | 1106 |
| 10 | ANTIPSYCHOTICS | Author keyword | 614 | 42% | 2% | 1137 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | BIPOLAR DISORDERS | 2068 | 40% | 8% | 4006 | Search BIPOLAR+DISORDERS | Search BIPOLAR+DISORDERS |
| 2 | ELECTROCONVULSIVE THERAPY | 1261 | 69% | 2% | 1089 | Search ELECTROCONVULSIVE+THERAPY | Search ELECTROCONVULSIVE+THERAPY |
| 3 | OLANZAPINE | 835 | 56% | 2% | 1027 | Search OLANZAPINE | Search OLANZAPINE |
| 4 | RISPERIDONE | 790 | 55% | 2% | 990 | Search RISPERIDONE | Search RISPERIDONE |
| 5 | CLOZAPINE | 685 | 45% | 2% | 1148 | Search CLOZAPINE | Search CLOZAPINE |
| 6 | ANTIPSYCHOTICS | 614 | 42% | 2% | 1137 | Search ANTIPSYCHOTICS | Search ANTIPSYCHOTICS |
| 7 | MANIA | 542 | 47% | 2% | 856 | Search MANIA | Search MANIA |
| 8 | SCHIZOPHRENIA | 517 | 12% | 8% | 3996 | Search SCHIZOPHRENIA | Search SCHIZOPHRENIA |
| 9 | ATYPICAL ANTIPSYCHOTICS | 463 | 58% | 1% | 528 | Search ATYPICAL+ANTIPSYCHOTICS | Search ATYPICAL+ANTIPSYCHOTICS |
| 10 | NEUROLEPTIC MALIGNANT SYNDROME | 459 | 80% | 1% | 286 | Search NEUROLEPTIC+MALIGNANT+SYNDROME | Search NEUROLEPTIC+MALIGNANT+SYNDROME |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | I DISORDER | 1978 | 81% | 2% | 1182 |
| 2 | ATYPICAL ANTIPSYCHOTICS | 1402 | 57% | 3% | 1684 |
| 3 | RISPERIDONE | 1293 | 49% | 4% | 1898 |
| 4 | OLANZAPINE | 1278 | 54% | 3% | 1645 |
| 5 | MANIA | 1142 | 56% | 3% | 1396 |
| 6 | ECT | 940 | 65% | 2% | 900 |
| 7 | HALOPERIDOL | 896 | 38% | 4% | 1887 |
| 8 | SCHIZOAFFECTIVE DISORDER | 832 | 52% | 2% | 1119 |
| 9 | SCHIZOPHRENIA | 712 | 14% | 10% | 4906 |
| 10 | CLOZAPINE | 679 | 36% | 3% | 1503 |
Journals |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | JOURNAL OF CLINICAL PSYCHIATRY | 1198 | 38% | 5% | 2537 |
| 2 | JOURNAL OF ECT | 958 | 74% | 1% | 701 |
| 3 | JOURNAL OF AFFECTIVE DISORDERS | 824 | 31% | 4% | 2240 |
| 4 | BIPOLAR DISORDERS | 653 | 59% | 1% | 730 |
| 5 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 623 | 43% | 2% | 1106 |
| 6 | CONVULSIVE THERAPY | 573 | 87% | 1% | 283 |
| 7 | INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 519 | 47% | 2% | 824 |
| 8 | PHARMACOPSYCHIATRY | 243 | 32% | 1% | 629 |
| 9 | AMERICAN JOURNAL OF PSYCHIATRY | 222 | 15% | 3% | 1323 |
| 10 | JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY | 219 | 39% | 1% | 438 |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis | 2009 | 538 | 105 | 84% |
| Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013 | 2013 | 126 | 349 | 79% |
| Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review | 2015 | 6 | 54 | 76% |
| Diabetes mellitus and severe mental illness: mechanisms and clinical implications | 2015 | 6 | 102 | 75% |
| Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data | 2015 | 12 | 88 | 39% |
| Cognitive endophenotypes of bipolar disorder: A meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives | 2009 | 299 | 71 | 83% |
| Second-generation (atypical) antipsychotics and metabolic effects - A comprehensive literature review | 2005 | 739 | 197 | 79% |
| Cognitive dysfunction in unipolar depression: Implications for treatment | 2014 | 23 | 66 | 88% |
| A Critical Appraisal of Neuroimaging Studies of Bipolar Disorder: Toward a New Conceptualization of Underlying Neural Circuitry and a Road Map for Future Research | 2014 | 22 | 143 | 86% |
| Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies | 2013 | 66 | 35 | 74% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | INT MOOD | 208 | 77% | 0.3% | 141 |
| 2 | BIPOLAR DISORDERS PROGRAM | 189 | 63% | 0.4% | 189 |
| 3 | INT CONSORTIUM BIPOLAR DISORDER | 94 | 85% | 0.1% | 50 |
| 4 | MOOD DISORDERS PROGRAM | 91 | 42% | 0.3% | 169 |
| 5 | BIPOLAR DISORDER PROGRAM | 86 | 60% | 0.2% | 94 |
| 6 | WESTERN PSYCHIAT CLIN | 79 | 17% | 0.8% | 418 |
| 7 | MOOD DISORDERS UNIT | 73 | 46% | 0.2% | 118 |
| 8 | BIPOLAR DISORDERS | 72 | 67% | 0.1% | 65 |
| 9 | DEP S CLIN PROGRAM | 70 | 38% | 0.3% | 146 |
| 10 | BIPOLAR PSYCHOT DISORDERS PROGRAM | 69 | 66% | 0.1% | 63 |
Related classes at same level (level 3) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000006672 | PSYCHIATRY//SCHIZOPHRENIA//SCHIZOPHRENIA RESEARCH |
| 2 | 0.0000003489 | DOPAMINE//PSYCHOPHARMACOLOGY//NUCLEUS ACCUMBENS |
| 3 | 0.0000003123 | CREATINE//MAGNETIC RESONANCE SPECTROSCOPY//LITHIUM |
| 4 | 0.0000002733 | OBSESSIVE COMPULSIVE DISORDER//TOURETTE SYNDROME//ELDER ABUSE |
| 5 | 0.0000002227 | MINDFULNESS//ALEXITHYMIA//SOCIAL PHOBIA |
| 6 | 0.0000001680 | PARKINSONS DISEASE//ALPHA SYNUCLEIN//MOVEMENT DISORDERS |
| 7 | 0.0000001646 | CYTOCHROME P450//GSTM1//GSTT1 |
| 8 | 0.0000001646 | CARDIAC REHABILITATION//CARDIOVASCULAR REACTIVITY//TYPE D PERSONALITY |
| 9 | 0.0000001631 | OXYTOCIN//VASOPRESSIN//CORTICOTROPIN RELEASING FACTOR |
| 10 | 0.0000001498 | SEASONAL AFFECTIVE DISORDER//WINTER DEPRESSION//HEAT WAVES |